| 标题： | 中国肝细胞癌合并门静脉癌栓诊疗指南（2021年版） |
| title： | Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China |
| 版本： | 更新版 |
| version： | Updated |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床医生 |
| Guide users： | clinician |
| 证据分级方法： | Ia 证据源于对多项随机对照研究的Meta分析结果 Ib 证据源于至少一项设计良好的随机对照研究结果 IIa 证据源于至少一项设计良好的前瞻性非随机对照研究结果 IIb 证据源自至少一项设计良好的其他类型干预性临床研究结果 III 证据源于设计良好的非干预性研究，如描述性研究，相关性研究等 IV 证据源于专家委员会报告或权威专家的临床经验报道 |
| Evidence grading method： | Ia Evidences are originated from the meta-analysis results of various RCTs Ib Evidences are originated from the results of at least one well-designed RCT IIa Evidences are originated from the results of at least one well-designed perspective non-RCT IIb Evidences are originated from the results of at least one well-designed interventional clinical research of other type III Evidences are originated from the well-designed non-interventional clinical researches, such as descriptive researches and relevant researches IV Evidences are originated from the reports made by committee of experts or the clinical reports of authoritative experts |
| 制定单位： | 中国医师协会肝癌专业委员会 |
| Formulating unit： | China Association of Liver Cancer |
| 注册时间： | 2022-02-22 |
| Registration time： | |
| 注册编号： | IPGRP-2022CN081 |
| Registration number： | |
| 指南制订的目的： | 规范肝癌合并 门静脉癌栓的诊疗 |
| Purpose of the guideline： | To standardize the diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus |
